SALT Holding Corp. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001996109

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocused how tags are computed

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Q2 2026 · 25 positions · Total reported value $188.75M · Top-10 concentration 90.3% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 19.2% · 3 new · 1 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +5.9% · vs SPY -8.9% · Prev Value $161.13M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, SALT Holding Corp. disclosed 25 equity positions with a combined reported value of $188.75M. The filing implies a focused portfolio: its ten largest positions account for 90.3% of reported value. HoldingsHub classifies the profile as Small / Focused.

The largest disclosed positions as of Q2 2026 were VOD ($50.53M), RACE ($24.86M), AZN ($17.68M). By sector, the heaviest allocations are Health Care 31.7%, Communication Services 26.8%. Versus the prior quarter, allocation shifted toward Technology (+5.2pp), Health Care (+4.4pp) and away from Energy (-0.6pp), Industrials (-1.1pp).

Versus the prior quarter, SALT Holding Corp. opened 3 new positions, trimmed 1 and fully exited 1, a turnover rate of 19.2% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q2 2026 were GSK ($12.34M), UL ($2.22M), QGEN ($705.75K).

Of the 1 positions fully exited versus the prior quarter, the largest were BP ($225.60K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • GSK GSK PLC · $12.34M
  • UL UNILEVER PLC FSPONSORED ADR 1 ADR REPS 1 ORD SHS · $2.22M
  • QGEN QIAGEN N.V. · $705.75K

Fully Exited (vs previous quarter)

  • BP BP PLC SPONSORED ADR · prev qtr: $225.60K

Insider Transactions (Form 4)

Latest SALT Holding Corp. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

SALT Holding Corp. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 25 positions worth $188.75M in total. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).

Portfolio Structure

  • 25 positions · $188.75M reported value (Q2 2026)
  • Top 10 holdings = 90.3% of reported value
  • Largest position: VOD (VODAFONE GROUP PLC) at 26.8%
  • Average position size: $7.55M

Sector Tilt

  • Health Care 31.7%
  • Communication Services 26.8%
  • Information Technology 15.5%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 1 added, 1 reduced, 1 exited
  • 20 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The SALT Holding Corp. fund maintained a conservative stance with a slight inclination towards growth sectors, as evidenced by the addition of GSK and the increase in STM's position. The fund's decision to hold positions steady across most sectors suggests a wait-and-see approach to market conditions. 2. Key Moves: - Added: GSK (Health Care), STM (Technology) - Reduced: None - Increased: STM (Technology) by 60.8% QoQ - No Change: VOD, RACE, AZN, NOK, BUD, NVO, NVS, BTI 3. Portfolio Structure: - Passive/Active: The portfolio appears to be more passive, with a low turnover rate and a focus on holding positions. - Sector Bias: The fund has a strong bias towards Health Care and Technology, with these sectors accounting for over 40% of the total portfolio. - Risk Appetite: The fund's risk appetite is moderate, with a balanced mix of sectors and no significant reduction in positions. 4. Per-Holding One-Liner: - VOD: Vodafone Group PLC is a telecommunications company. - RACE: Ferrari N.V. is an Italian luxury sports car manufacturer. - AZN: AstraZeneca PLC is a British multinational pharmaceutical and biotechnology company. - NOK: Nokia Corp. is a Finnish multinational telecommunications, information technology, and consumer electronics company. - BUD: Anheuser Busch InBev SA NV is a Belgian multinational beverage and brewing company. - GSK: GSK PLC is a British multinational pharmaceutical and biotechnology company. - NVO: Novo-Nordisk A/S is a Danish multinational pharmaceutical company. - NVS: Novartis AG is a Swiss multinational pharmaceutical company. - STM: STMicroelectronics N.V. is a European multinational semiconductor and electronics company. - BTI: British American Tobacco PLC is a British multinational tobacco company. 5. One-Sentence Style Summary: The SALT Holding Corp. fund maintained a conservative stance in Q2 2026, with a slight emphasis on Health Care and Technology sectors, while holding positions steady across other sectors, reflecting a cautious yet growth-oriented investment approach.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 3.82M $50.53M 26.77%
26.77%
Hold
2 66.77K $24.86M 13.17%
13.17%
Hold
3 93.25K $17.68M 9.37%
9.37%
Hold
4 1.08M $14.28M 7.57%
7.57%
Hold
5 154.17K $12.70M 6.73%
6.73%
Hold
6 235.46K $12.34M 6.54%
6.54%
New
7 256.13K $12.28M 6.50%
6.50%
Hold
8 66.84K $10.48M 5.55%
5.55%
Hold
9 125.90K $9.43M 5.00%
5.00%
Add
10 95.59K $5.90M 3.13%
3.13%
Hold
11 31.86K $2.56M 1.36%
1.36%
Hold
12 36.90K $2.22M 1.18%
1.18%
New
13 198.50K $2.21M 1.17%
1.17%
Reduce
14 62.70K $2.18M 1.16%
1.16%
Hold
15 728 $1.45M 0.77%
0.77%
Hold
16 19.70K $1.19M 0.63%
0.63%
Hold
17 6.63K $1.02M 0.54%
0.54%
Hold
18 9.76K $918.11K 0.49%
0.49%
Hold
19 150.49K $863.83K 0.46%
0.46%
Hold
20 9.94K $770.59K 0.41%
0.41%
Hold
21 18.05K $705.75K 0.37%
0.37%
New
22 22.00K $690.80K 0.37%
0.37%
Hold
23 15.17K $563.83K 0.30%
0.30%
Hold
24 500 $463.88K 0.25%
0.25%
Hold
25 23.91K $461.90K 0.24%
0.24%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 90% R 90% F1 90% (modelled on 2026-Q1; 9/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 70% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (5 quarters)

Avg precision 70% · recall 71% · F1 70% · avg rank error 2.9 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2025-Q2 60% 86% 71% ASML · LOGI · RIO · RACE · GSK · NVO · AZN · VOD · ARGX · MT VOD · RACE · STM · NVO · LOGI · MT · ARGX
2025-Q3 71% 50% 59% VOD · RACE · STM · NVO · LOGI · MT · ARGX VOD · RACE · BUD · NOK · DEO · STM · AZN · LOGI · MT · MIAX
2025-Q4 60% 60% 60% VOD · RACE · BUD · NOK · DEO · STM · AZN · LOGI · MT · MIAX VOD · RACE · AZN · BUD · NOK · BTI · DEO · ERIC · STLA · SAP
2026-Q1 70% 70% 70% VOD · RACE · AZN · BUD · NOK · BTI · DEO · ERIC · STLA · SAP VOD · RACE · AZN · BUD · NVS · NVO · NOK · BTI · STM · DEO
2026-Q2 ★ 90% 90% 90% VOD · RACE · AZN · BUD · NVO · NVS · NOK · BTI · STM · FRO VOD · RACE · AZN · NOK · BUD · GSK · NVO · NVS · STM · BTI

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did SALT Holding Corp. buy in 2026-Q2?

In its 2026-Q2 13F filing, SALT Holding Corp. reported 25 equity positions worth $188.75M in aggregate; its largest disclosed positions were VOD ($50.53M), RACE ($24.86M), AZN ($17.68M).

How large is SALT Holding Corp.'s portfolio?

SALT Holding Corp. reported $188.75M of long equity holdings across 25 positions as of 2026-Q2. Top-10 holdings account for 90.3% of reported value.

What is SALT Holding Corp.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/salt-holding/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →